AbbVie Inc.’s Allergan and its Korean partner Medytox Inc. won the first round of a U.S. trade dispute in which they are trying to block imports of Evolus Inc.’s Jeuveau, a rival to the Botox wrinkle treatment, Bloomberg reports.